This inventor holds 1 USPTO granted patent. Top assignee: The Ohio State University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Matthew A. Sermersheim: Inventor in Viral Infection Treatment
Introduction
Matthew A. Sermersheim is an inventor associated with The Ohio State University. Based on the information provided, his work includes research into approaches for preventing and treating viral infection-induced organ failure.
Latest Patents
Sermersheim is credited with 1 patent, titled “Prevention and Treatment of Viral Infection and Viral Infection-Induced Organ Failure.” The patent describes compositions and methods intended to prevent, reverse, or treat organ failure caused by viral infections. It also identifies potential applications in preventing or treating COVID-19 and influenza.
The disclosed approaches use MG53, including recombinant human MG53. They also describe compositions designed to express and release MG53 after administration to a subject.
Career Highlights
Sermersheim’s listed patent connects his work with therapeutic strategies involving MG53 and viral disease. The patent record identifies The Ohio State University as the company or institution associated with him.
Collaborations
The provided information names Adam D. Kenney and Chuanxi Cai as some of Sermersheim’s coworkers. Their inclusion indicates a connection to a broader research community working in related areas.
Conclusion
Matthew A. Sermersheim’s listed invention focuses on MG53-based methods and compositions for addressing viral infections and related organ failure, including conditions associated with COVID-19 and influenza.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile